Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ingevity Corporation (NYSE: NGVT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered context to help interpret them. Ingevity is a specialty materials and chemical manufacturer organized into three segments—Performance Materials, Advanced Polymer Technologies and Performance Chemicals—and its filings document how these businesses are managed, restructured and financed over time.
Investors can use Ingevity’s Form 10-K annual reports and Form 10-Q quarterly reports to review segment information, including sales and EBITDA for Performance Materials (activated carbon), Advanced Polymer Technologies (caprolactone polymers) and Performance Chemicals (specialty chemicals and pavement or road technologies). These reports also describe the applications for Ingevity’s products, such as adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings, lubricants, oil drilling and automotive components.
Ingevity’s Form 8-K current reports are particularly important for tracking material events that affect NGVT stock. Recent 8-K filings detail the asset purchase agreement and subsequent amendment with Mainstream Pine Products, LLC for the sale of the North Charleston crude tall oil refinery and the majority of the Industrial Specialties product line, the classification of those operations as discontinued, and the completion of the transaction. Other 8-Ks describe leadership transitions in finance and business segments, the completion of a portfolio review and the decision to explore strategic alternatives for the Advanced Polymer Technologies segment and the Performance Chemicals Road Markings business, as well as preliminary earnings announcements.
On this page, AI-generated summaries highlight the key points of each filing, helping users quickly understand what a lengthy 8-K, 10-Q or 10-K means for Ingevity’s portfolio, margins, cash flow and capital allocation. Filings related to stock repurchases, strategic divestitures and executive changes are surfaced so that investors can monitor how the company is reshaping its specialty chemicals and materials portfolio. Users can also review exhibits referenced in 8-Ks, such as asset purchase agreements and recast financial information, to gain deeper insight into the structure and impact of major transactions.
Ingevity Corp senior vice president Clarence Reid Clontz Jr. reported performance-based equity compensation activity involving company common stock. On February 26, 2026, he acquired 187 shares of common stock at $0.00 per share as a grant related to performance-based restricted stock awards (PSUs) whose performance goals were certified and settled in stock.
On the same date, 69 shares were disposed of at $70.52 per share through shares withheld by the company to cover tax withholding obligations tied to the PSU vesting, rather than an open-market sale. After these transactions, he directly held 7,363 common shares, which includes 216 shares previously purchased through the company’s employee stock purchase plan.
Ingevity Corporation is reshaping its portfolio around a streamlined “New Ingevity” model after a comprehensive strategic review. It sold its North Charleston crude tall oil refinery and most of the Performance Chemicals industrial specialties product line on January 1, 2026, which are reported as discontinued operations.
New Ingevity will center on two higher‑margin businesses, Performance Materials and Pavement Technologies, while the company explores strategic alternatives for the Advanced Polymer Technologies segment and the road markings product line, targeted for completion by the end of 2026. In 2025, segment revenue was $606.9 million for Performance Materials, $400.5 million for Performance Chemicals, and $160.2 million for Advanced Polymer Technologies. Ingevity also faces an approximately $85.0 million antitrust judgment in the BASF dispute, with $95.4 million accrued including post‑judgment interest and payment expected in the second quarter of 2026, while reporting a 29% reduction in personal and process safety incidents versus 2024.
Ingevity Corporation reported 2025 results marked by strong cash generation but a GAAP loss driven by large non‑cash charges. Net sales from continuing operations were $1.17 billion, down about 3%, while adjusted EBITDA was $373.0 million with margin expanding to 31.9%.
The company posted a net loss of $167.1 million, or $4.61 per share, mainly from $293.1 million in non‑cash impairments tied to Advanced Polymer Technologies and Road Markings. Operating cash flow rose to $331.2 million and free cash flow to $273.5 million, improving net leverage to 2.6x. Ingevity sold its North Charleston crude tall oil refinery and most Industrial Specialties, and is exploring strategic alternatives for Advanced Polymer Technologies and Road Markings. For 2026, it guides to net sales of $1.1–$1.2 billion, adjusted EBITDA of $380–$400 million, adjusted EPS of $4.80–$5.20, and free cash flow of $225–$250 million, excluding about $95 million of litigation-related payments to BASF.
Ingevity Corporation announced planned board transitions tied to its 2026 Annual Meeting of Stockholders. Founding directors Daniel F. Sansone and Jean S. Blackwell will not stand for re-election; Sansone is stepping down under the board’s mandatory retirement age policy, while Blackwell is concluding a decade of service that included time as board chair.
The company states that these decisions are part of normal board refreshment and are not due to any disagreement regarding operations, policies or practices. Following the meeting, Ingevity plans to reduce the size of its board from 11 to 9 members to align governance with its future scope and strategic direction.
Ingevity Corp director reports routine stock-based compensation. Director Francis David Segal acquired 396 shares of Ingevity common stock on 01/02/2026 at a price of $60.09 per share. Following this transaction, he beneficially owns 6,051 shares of Ingevity common stock in direct ownership.
The reported shares represent vested deferred stock units that were granted under Ingevity’s director compensation programs, where the director elected to receive deferred stock units instead of cash quarterly director fees. These deferred stock units will convert into an equal number of Ingevity common shares when his service on the board ends, in line with the company’s Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
Ingevity Corp director reports stock-based compensation transaction
A director of Ingevity Corp reported acquiring 479 shares of the company’s common stock on 01/02/2026 at a price of $60.09 per share. These shares represent vested deferred stock units the director elected to receive instead of quarterly cash director fees, under Ingevity’s Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. After this transaction, the director beneficially owns 8,779 shares of Ingevity common stock in direct ownership. The deferred stock units will convert into an equal number of common shares when the director’s board service ends.
Ingevity Corporation completed a previously announced transaction to sell substantially all of the assets, rights and certain liabilities of its industrial specialties product line and its North Charleston, South Carolina crude tall oil refinery to Mainstream Pine Products, LLC as of January 1, 2026.
At closing, the parties signed an amendment to their Asset Purchase Agreement that narrows the deal by excluding non-lignin dispersant products sold to existing customers for agricultural chemical applications, while leaving the rest of the agreement in full force and effect.
Ingevity later issued a press release on January 5, 2026 confirming completion of the transaction, highlighting a significant reshaping of the company’s portfolio around businesses that remain outside the divested industrial specialties and crude tall oil refinery operations.
Ingevity Corp senior vice president of operations Clarence Reid Clontz, Jr. reported his beneficial ownership in the company as of the stated event date. He directly holds 7,029 shares of common stock.
He also holds employee stock options granted under the Ingevity Corporation 2016 Omnibus Incentive Plan. These options cover 217 shares at $53.11 per share that vested in full on February 27, 2020, 496 shares at $74.91 per share that vested in full on February 28, 2021, and 351 shares at $115.22 per share that vested in three equal installments between February 28, 2020 and February 28, 2022.
Ingevity Corporation reported upcoming leadership changes in its finance and operations teams. The company announced that Executive Vice President and Chief Financial Officer Mary Dean Hall will transition out of her CFO role effective May 1, 2026, and then serve in an advisory capacity for one year to support continuity.
Phillip J. Platt, currently Senior Vice President, Finance and Chief Accounting Officer, has been appointed to succeed her as Senior Vice President and Chief Financial Officer and will join the executive leadership team on May 1, 2026. Platt has been with Ingevity since 2015 in multiple senior finance roles, including leading implementation of the global ERP system and overseeing financial reporting, treasury, investor relations, and business transformation.
The company also disclosed that Richard White, Senior Vice President and President, Performance Chemicals, will depart on May 1, 2026 after moving to a special projects role beginning January 1, 2026. A related press release also announced the appointment of Clarence Reid Clontz, Jr. as Senior Vice President, Operations.
Ingevity Corporation reported that it has completed its previously announced portfolio review and is exploring strategic alternatives for its Advanced Polymer Technologies segment and its Performance Chemicals Road Markings business. This means the company is formally assessing options such as potential sales, partnerships, or other structural changes for these operations.
The company also stated that, as part of its efforts to return meaningful capital to stockholders, it has completed over $30 million in stock repurchases during the fourth quarter of 2025. These buybacks reduce the number of shares in the market and represent a direct way of returning cash to shareholders.